| Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy CN Andreassen, C Grau, JC Lindegaard Seminars in radiation oncology 13 (1), 62-72, 2003 | 276 | 2003 |
| Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes CN Andreassen, J Alsner, M Overgaard, J Overgaard Radiotherapy and Oncology 69 (2), 127-135, 2003 | 268 | 2003 |
| Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it? CN Andreassen, J Alsner, J Overgaard Radiotherapy and Oncology 64 (2), 131-140, 2002 | 253 | 2002 |
| Genetic variants and normal tissue toxicity after radiotherapy: a systematic review CN Andreassen, J Alsner Radiotherapy and oncology 92 (3), 299-309, 2009 | 207 | 2009 |
| Genetic predictors of adverse radiotherapy effects: the Gene-PARE project AY Ho, DP Atencio, S Peters, RG Stock, SC Formenti, JA Cesaretti, ... International Journal of Radiation Oncology* Biology* Physics 65 (3), 646-655, 2006 | 168 | 2006 |
| TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer CN Andreassen, J Alsner, J Overgaard, C Herskind, J Haviland, R Owen, ... Radiotherapy and Oncology 75 (1), 18-21, 2005 | 156 | 2005 |
| Genetic markers for prediction of normal tissue toxicity after radiotherapy J Alsner, CN Andreassen, J Overgaard Seminars in radiation oncology 18 (2), 126-135, 2008 | 135 | 2008 |
| Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATMndash; a … CN Andreassen, J Alsner, M Overgaard, FB Sørensen, J Overgaard International journal of radiation biology 82 (8), 577-586, 2006 | 129 | 2006 |
| Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? CN Andreassen Acta Oncologica 44 (8), 801-815, 2005 | 129 | 2005 |
| Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients CN Andreassen, BS Rosenstein, SL Kerns, H Ostrer, D De Ruysscher, ... Radiotherapy and Oncology 121 (3), 431-439, 2016 | 125 | 2016 |
| Radiogenomics: radiobiology enters the era of big data and team science BS Rosenstein, CM West, SM Bentzen, J Alsner, CN Andreassen, D Azria, ... International journal of radiation oncology, biology, physics 89 (4), 709-713, 2014 | 123 | 2014 |
| ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy CN Andreassen, J Overgaard, J Alsner, M Overgaard, C Herskind, ... International Journal of Radiation Oncology* Biology* Physics 64 (3), 776-783, 2006 | 116 | 2006 |
| Radiogenomics–current status, challenges and future directions CN Andreassen, LMH Schack, LV Laursen, J Alsner Cancer letters 382 (1), 127-136, 2016 | 89 | 2016 |
| Searching for genetic determinants of normal tissue radiosensitivity–are we on the right track? CN Andreassen Radiotherapy and oncology 97 (1), 1-8, 2010 | 84 | 2010 |
| Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity GC Barnett, RM Elliott, J Alsner, CN Andreassen, O Abdelhay, NG Burnet, ... Radiotherapy and Oncology 105 (3), 289-295, 2012 | 81 | 2012 |
| Radiogenomics: the search for genetic predictors of radiotherapy response SL Kerns, CM L West, CN Andreassen, GC Barnett, SM Bentzen, ... Future oncology 10 (15), 2391-2406, 2014 | 76 | 2014 |
| STROGAR–strengthening the reporting of genetic association studies in radiogenomics SL Kerns, D De Ruysscher, CN Andreassen, D Azria, GC Barnett, ... Radiotherapy and Oncology 110 (1), 182-188, 2014 | 76 | 2014 |
| Data-based radiation oncology: design of clinical trials in the toxicity biomarkers era D Azria, A Lapierre, S Gourgou, D De Ruysscher, J Colinge, P Lambin, ... Frontiers in oncology 7, 83, 2017 | 39 | 2017 |
| Radiation therapy outcomes models in the era of radiomics and radiogenomics: uncertainties and validation I El Naqa, G Pandey, H Aerts, JT Chien, CN Andreassen, A Niemierko, ... International journal of radiation oncology, biology, physics 102 (4), 1070-1073, 2018 | 34 | 2018 |
| Conducting radiogenomic research–do not forget careful consideration of the clinical data CN Andreassen, GC Barnett, JA Langendijk, J Alsner, D De Ruysscher, ... Radiotherapy and Oncology 105 (3), 337-340, 2012 | 32 | 2012 |
